Amgen Should Start Paying a Dividend [View article]
I'm not sure anyone's too concerned about Amgen not being around for long... this is a 70 billion dollar company! But your point is well stated. Most pharma companies pay generous dividends, and Amgen can certainly afford it with nearly 5 billion dollars of free cash flow. With no generic biodrugs in the U.S. for the forseeable future, their legacy drugs will continue to bring in loads of cash.
Amgen Should Start Paying a Dividend [View article]
Steve
magicdiligence.com
Amgen Prevents Biotechs from Reaching Profitability [View article]
Steve
magicdiligence.com